COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,844 Articles (22,553 medRxiv, 8,291 bioRxiv)

Most recent first Previous |  Page 2143: Articles 21421-21430  | Next

Two-tiered SARS-CoV-2 seroconversion screening in the Netherlands and stability of nucleocapsid, spike protein domain 1 and neutralizing antibodies
Garritsen, A., Scholzen, A., van den Nieuwenhof, D. W., Smits, A. P., Datema, E. S., van Galen, L. S., Kouwijzer, M. L.
10.1101/2020.10.07.20187641 — Posted: 2020-10-09
Remote home monitoring (virtual wards) during the COVID-19 pandemic: a living systematic review
Vindrola-Padros, C., Singh, K., Sidhu, M. S., Georghiou, T., Sherlaw-Johnson, C., Tomini, S. M., Inada-Kim, M., Kirkham, K., Streetly, A., Fulop, N. J.
10.1101/2020.10.07.20208587 — Posted: 2020-10-09
SARS-CoV-2 Elicits Robust Adaptive Immune Responses Regardless of Disease Severity
Nielsen, S. S. F., Vibholm, L. K., Monrad, I., Olesen, R., Frattari, G. S., Pahus, M. H., Hojen, J. F., Gunst, J. D., Erikstrup, C., Holleufer, A., Hartmann, R., Ostergaard, L., Sogaard, O. S., Schleimann, M. H., Tolstrup, M.
10.1101/2020.10.08.331645 — Posted: 2020-10-09
Psychiatric Genomics Research During the COVID-19 Pandemic: A Survey of Psychiatric Genomics Consortium Researchers
Guintivano, J., Dick, D., Bulik, C. M.
10.1101/2020.10.08.331421 — Posted: 2020-10-08
Genome-scale identification of SARS-CoV-2 and pan-coronavirus host factor networks
Schneider, W. M., Luna, J. M., Hoffmann, H.- H., Sanchez-Rivera, F. J., Leal, A. A., Ashbrook, A. W., Le Pen, J., Michailidis, E., Ricardo-Lax, I., Peace, A., Stenzel, A. F., Lowe, S. W., MacDonald, M. R., Rice, C. M., Poirier, J. T.
10.1101/2020.10.07.326462 — Posted: 2020-10-08
Preferential recognition and antagonism of SARS-CoV-2 spike glycoprotein binding to 3-O-sulfated heparan sulfate
Tiwari, V., Tandon, R., Sankaranarayanan, N. V., Beer, J. C., Kohlmeir, E. K., Swanson-Mungerson, M., Desai, U. R.
10.1101/2020.10.08.331751 — Posted: 2020-10-08
CD8+ T cell responses in convalescent COVID-19 individuals target epitopes from the entireSARS-CoV-2 proteome and show kinetics of early differentiation
Kared, H., Redd, A. D., Bloch, E. M., Bonny, T. S., Sumatoh, H., Kairi, F., Carbajo, D., Abel, B., Newell, E. W., Bettinotti, M. P., Benner, S. E., Patel, E. U., Littlefield, K., Laeyendecker, O., Shoham, S., Sullivan, D., Casadevall, A., Pekosz, A., Nardin, A., Fehlings, M., Tobian, A. A., Quinn, T. C.
10.1101/2020.10.08.330688 — Posted: 2020-10-08 Discussion: Offsite
Misinterpretation of viral load in COVID-19.
Miranda, R. L., Guterres, A., Lima, C. H. d. A., Filho, P. N., Gadelha, M. R.
10.1101/2020.10.06.20208009 — Posted: 2020-10-08
Sars-Cov-2 in Argentina: Following Virus Spreading using Granger Causality
Larrosa, J. M. C.
10.1101/2020.10.06.20207993 — Posted: 2020-10-08
Mask mandates can limit COVID spread: Quantitative assessment of month-over-month effectiveness of governmental policies in reducing the number of new COVID-19 cases in 37 US States and the District of Columbia
Maloney, M. J., Rhodes, N. J., Yarnold, P. R.
10.1101/2020.10.06.20208033 — Posted: 2020-10-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).